UY34233A - ANTITUMORAL COMBINATION THAT INCLUDES OMBRABULINA AND CETUXIMAB, ASSOCIATED WITH RADIOTHERAPY - Google Patents
ANTITUMORAL COMBINATION THAT INCLUDES OMBRABULINA AND CETUXIMAB, ASSOCIATED WITH RADIOTHERAPYInfo
- Publication number
- UY34233A UY34233A UY0001034233A UY34233A UY34233A UY 34233 A UY34233 A UY 34233A UY 0001034233 A UY0001034233 A UY 0001034233A UY 34233 A UY34233 A UY 34233A UY 34233 A UY34233 A UY 34233A
- Authority
- UY
- Uruguay
- Prior art keywords
- ombrabulina
- cetuximab
- radiotherapy
- antitumoral combination
- antitumoral
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/16—Amides, e.g. hydroxamic acids
- A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
- A61K31/167—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide having the nitrogen of a carboxamide group directly attached to the aromatic ring, e.g. lidocaine, paracetamol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
- A61K39/39533—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum against materials from animals
- A61K39/3955—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum against materials from animals against proteinaceous materials, e.g. enzymes, hormones, lymphokines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Epidemiology (AREA)
- Endocrinology (AREA)
- Mycology (AREA)
- Dermatology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Immunology (AREA)
- Microbiology (AREA)
- Pain & Pain Management (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Saccharide Compounds (AREA)
Abstract
No escanear figura.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR1157044A FR2978663A1 (en) | 2011-08-01 | 2011-08-01 | ANTITUMOR COMBINATION COMPRISING OMBRABULIN AND CETUXIMAB ASSOCIATED WITH RADIOTHERAPY |
Publications (1)
Publication Number | Publication Date |
---|---|
UY34233A true UY34233A (en) | 2013-02-28 |
Family
ID=46832547
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
UY0001034233A UY34233A (en) | 2011-08-01 | 2012-08-01 | ANTITUMORAL COMBINATION THAT INCLUDES OMBRABULINA AND CETUXIMAB, ASSOCIATED WITH RADIOTHERAPY |
Country Status (5)
Country | Link |
---|---|
AR (1) | AR087393A1 (en) |
FR (1) | FR2978663A1 (en) |
TW (1) | TW201315461A (en) |
UY (1) | UY34233A (en) |
WO (1) | WO2013018018A1 (en) |
Family Cites Families (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4259598A (en) | 1979-12-20 | 1981-03-31 | General Electric Company | Charge transfer signal processing apparatus transversal filter |
EP1068870B1 (en) | 1998-04-03 | 2006-06-07 | Ajinomoto Co., Inc. | Antitumor agents |
US20020183266A1 (en) | 2001-03-15 | 2002-12-05 | Aventis Pharma, S.A. | Combination comprising combretastatin and anticancer agents |
DE60238408D1 (en) | 2001-06-25 | 2011-01-05 | Ajinomoto Kk | ANTITUMORAL AGENTS |
FR2838437B1 (en) | 2002-04-11 | 2004-06-04 | Aventis Pharma Sa | PROCESSES FOR THE PREPARATION OF COMBRETASTATINS |
FR2895258B1 (en) | 2005-12-22 | 2008-03-21 | Aventis Pharma Sa | COMBINATION COMPRISING COMBRETASTATIN AND ANTICANCER AGENTS |
US20090209496A1 (en) * | 2008-02-15 | 2009-08-20 | David Chaplin | Methods and compositions for enhancing the efficacy of rtk inhibitors |
FR2945210B1 (en) | 2009-05-07 | 2011-07-01 | Sanofi Aventis | ANTITUMOR COMBINATION COMPRISING AVE8062 AND SORAFENIB |
-
2011
- 2011-08-01 FR FR1157044A patent/FR2978663A1/en not_active Withdrawn
-
2012
- 2012-07-30 WO PCT/IB2012/053881 patent/WO2013018018A1/en active Application Filing
- 2012-07-31 AR ARP120102782A patent/AR087393A1/en not_active Application Discontinuation
- 2012-08-01 UY UY0001034233A patent/UY34233A/en not_active Application Discontinuation
- 2012-08-01 TW TW101127821A patent/TW201315461A/en unknown
Also Published As
Publication number | Publication date |
---|---|
FR2978663A1 (en) | 2013-02-08 |
WO2013018018A1 (en) | 2013-02-07 |
AR087393A1 (en) | 2014-03-19 |
TW201315461A (en) | 2013-04-16 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
UY4151Q (en) | VINCHA WITH HEADPHONES | |
UA117565C2 (en) | Novel rig-i ligands and methods for producing them | |
UY4281Q (en) | PLAYER | |
UY4210Q (en) | CHAIR | |
UY4223Q (en) | BANK | |
UY4153Q (en) | DRUMS | |
UY4152Q (en) | DRUMS | |
CL2012001192S1 (en) | Bottle. | |
UY4237Q (en) | STOOL | |
PH12017500071A1 (en) | Therapeutic agent for keratoconjunctive disorder | |
UY34233A (en) | ANTITUMORAL COMBINATION THAT INCLUDES OMBRABULINA AND CETUXIMAB, ASSOCIATED WITH RADIOTHERAPY | |
UY34232A (en) | ANTITUMORAL COMBINATION THAT INCLUDES OMBRABULIN AND CISPLATIN, ASSOCIATED WITH RADIOTHERAPY | |
TWD160310S (en) | Goggles | |
UY4267Q (en) | BOTTLE | |
UY4262Q (en) | BOTTLE | |
UY4163Q (en) | BOTTLE | |
UA91089U (en) | Use of bioglobin-y for correction of hypothyroid states in experiment | |
AU339705S (en) | Sofa | |
AU339704S (en) | Sofa | |
CL2012003733S1 (en) | Bottle | |
CL2012003732S1 (en) | Bottle | |
CL2012003504S1 (en) | Bottle | |
CL2012003141S1 (en) | Bottle | |
AU340959S (en) | Bottle | |
TWD162174S (en) | Humidifier |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
104 | Application deemed to be withdrawn (no substantive examination fee paid) |
Effective date: 20140528 |